Webinar: How to maximise value & avoid failure during life sciences dealmaking

Pills spilling out of a bottle

During this webinar, an expert panel of life sciences dealmaking veterans from AstraZeneca and Merck, with 100 years' collective experience, share their insights on key dealmaking strategies, best practices, and common pitfalls to avoid in order to maximise value and mitigate risk in life sciences dealmaking, and also answer audience questions.

Access the on-demand recording below to hear about:

  • The importance of collaboration as a driver of innovation
  • The current policy landscape and its impact on R&D and investment
  • The dos and don'ts for creating successful transaction agreements
  • Real-world takeaways on dealmaking and integration best practices
11-Apr-2023 23:40:47
Related Articles
Commercial real estate spotlight: life sciences

“Two roads diverged in a wood and I – I took the one less traveled by, and that has made all the difference.”1 Following on from my...

Commercial real estate spotlight: life sciences
by Harry Iles
Drug manufacturing laboratory equipment

“Two roads diverged in a wood and I – I took the one less traveled by, and that has made all the difference.”1 Following on from my...

Learn more ->
Navigating Digital Deals in Life Sciences Part 3 | Defining & Valuing the Asset

Welcome to the third of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Navigating Digital Deals in Life Sciences Part 3 | Defining & Valuing the Asset
by Philip Whitchelo

Welcome to the third of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Learn more ->
Navigating Digital Deals in Life Sciences Part 5 | Deal Structure, Terms and Series Conclusions

Welcome to the fifth and final episode in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Navigating Digital Deals in Life Sciences Part 5 | Deal Structure, Terms and Series Conclusions
by Philip Whitchelo

Welcome to the fifth and final episode in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Learn more ->